Mantis Photonics Launches Crowdfunding Campaign for Eye Screening Technology

Mantis Photonics, at the forefront of space-inspired technology, announced the launch of a crowdfunding campaign for its seed round. This initiative, hosted on the Capital Cel platform, aims to fuel the development of Mantis Photonics’ noninvasive health screening technology using space-based innovations.

Mantis Photonics is pioneering the use of space technology to revolutionize health screening, employing a patented multi-color imaging technology that scans the retina. The vision is clear – to diagnose a broad spectrum of diseases, including prevalent eye conditions such as Diabetic Retinopathy and Age-related Macular Degeneration (AMD), as well as complex neurodegenerative diseases like Alzheimer's.

The company recognizes the critical importance of early diagnosis, especially for diseases like oncology and AMD, where positive results have been observed in initial clinical trials. Early detection facilitates prompt treatment, potentially saving millions of individuals from the debilitating consequences of blindness, dementia, and oncological challenges.

Mantis Photonics has successfully developed two prototypes and rigorously tested them in clinical trials. Encouragingly, initial trial results have shown promise, particularly in the realms of oncology and AMD. The company is now seeking support through its seed round to further refine and advance these pioneering technologies.

The lack of infrastructure and specialized expertise has hindered the early diagnosis of various diseases. Mantis Photonics is poised to bridge this gap by offering an innovative solution that not only enables early disease screening but has the potential to save billions in healthcare costs.

To join the movement and support Mantis Photonics in their mission, visit the link.

To get more information, register the company’s webinar on Thursday the 11th here.